Protoveratrines
[16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2,3-dihydroxy-2-methylbutanoate;[16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2-hydroxy-2-methylbutanoate
Also Known As: Veralba|Provell|Protoveratrines|Tensatrin|Ebrantan|Protoveratrine|Cryptenamine|Puroverine|Protoveratrine A and B|Pvs-295|Protoveratrines A and B|PROTOVERATRINE, A+B|PROTOVERATRINE (A + B)|Protoveratrine A & Protoveratrine B|Protoveratrine A, mixt. with protoveratrine B|[16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2,3-dihydroxy-2-methylbutanoate;[16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2-hydroxy-2-methylbutanoate|[diacetoxy-tetrahydroxy-trimethyl-(2-methylbutanoyloxy)[?]yl] 2,3-dihydroxy-2-methyl-butanoate; [diacetoxy-tetrahydroxy-trimethyl-(2-methylbutanoyloxy)[?]yl] 2-hydroxy-2-methyl-butanoate|Cevane-3,4,6,7,14,15,16,20-octol, 4,9-epoxy-, 6,7-diacetate 3-(2,3-dihydroxy-2-methylbutanoate) 15-(2-methylbutanoate), [3.beta.(2R,3R),4.alpha.,6.alpha.,7.alpha.,15.alpha.(R),16.beta.]-, mixt. with [3.beta.(S),4.alpha.,6.alpha.,7.alpha.,15.alpha.(R),16.beta.]-4,9-epoxycevane-3,4,6,7,14,15,16,20-octol 6,7-diacetate 3-(2-hydroxy-2-methylbutanoate) 15-(2-methylbutanoate)|Cevane-3,6,7,14,15,16,20-octol, 4,9-epoxy-, 6,7-diacetate 3-(2,3-dihydroxy-2-methylbutanoate) 15-(2-methylbutanoate), [3.beta.(2R,3R),4.alpha.,6.alpha.,7.alpha.,15.alpha.(R),16.beta.]-, mixt. with[3.beta.(S),4.alpha.,6.alpha.,7.alpha.,15.alpha.(R),16.beta.]-4,9-epoxycevane-3,4,6,7,14,15,16,20-octol 6,7-diacetate 3-(2-hydroxy-2-methylbutanoate) 15-(2-methylbutanoate)
| Molecular Formula | C82H126N2O29 |
|---|---|
| Molecular Weight | 1602.8446 g/mol |
| LogP | 2.1852 |
| Topological Polar Surface Area | 458.0 Ų |
| Hydrogen Bond Donors | 11 |
| Hydrogen Bond Acceptors | 31 |
| Rotatable Bonds | 24 |
| Exact Mass | 1602.8446 |
| Monoisotopic Mass | 1602.8446 |
| Heavy Atoms | 113 |
| Complexity | 3290.0 |
Chemical Identifiers
| CAS Number | 8053-18-7 |
|---|---|
| SMILES | CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(C(C6C7(C5(C4)OC6(C(CC7)OC(=O)C(C)(CC)O)O)C)OC(=O)C)OC(=O)C)O)O.CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(C(C6C7(C5(C4)OC6(C(CC7)OC(=O)C(C)(C(C)O)O)O)C)OC(=O)C)OC(=O)C)O)O |
| InChIKey | SFCJOAFKJHVNCF-UHFFFAOYSA-N |
Product Overview
Protoveratrines (CAS 8053-18-7), with molecular formula C82H126N2O29 and molecular weight 1602.8446 g/mol. IUPAC: [16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2,3-dihydroxy-2-methylbutanoate;[16,17-diacetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-(2-methylbutanoyloxy)-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 2-hydroxy-2-methylbutanoate.
Protoveratrines is a custom synthesis product. We offer services from milligram to kilogram scale.
Request a Quote »